Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs / European Monitoring Centre for Drugs and Drug Addiction
Autor institucional: EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDAIdioma: Inglês.Publicação: Luxembourg : Office for Official Publications of the European Communities, 2002Descrição física: 92 p.; 21 cmColeção: Implemention of the joint action; 4ISBN: 9291681229Assunto: 6631 | 6333 | 581 | 1370 | 103050 | 6334Localização e Cota : DRO321 Resumo: Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Europol-EMCDDS progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risk of GHB. Public health risk of GHB - epidemiological evidence.| Item type | Current location | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Monografias | Biblioteca da Direção-Geral de Reinserção e Serviços Prisionais | DRO321 (Browse shelf) | 4435 | Available | DGRSP4435526872 |
Informação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https://www.emcdda.org
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Europol-EMCDDS progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risk of GHB. Public health risk of GHB - epidemiological evidence.
There are no comments for this item.